Goldman Sachs Group Inc Zynex Inc Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Zynex Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 77,075 shares of ZYXI stock, worth $43,932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,075
Previous 145,838
47.15%
Holding current value
$43,932
Previous $376,000
70.48%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ZYXI
# of Institutions
57Shares Held
4.65MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.24MShares$708,5710.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA921KShares$525,1220.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny296KShares$168,7080.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA230KShares$130,9020.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY230KShares$130,8280.0% of portfolio
About ZYNEX INC
- Ticker ZYXI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Distribution
- Shares Outstandng 37,453,400
- Market Cap $21.3M
- Description
- Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...